Time will tell

GLP-1 receptor agonists have been researched for decades, but there’s still much to discover. Professor Filip Knop from the University of Copenhagen outlines the five questions he would like to see answered by future research, such as will their effect on HbA1c remain for long periods and will they be effective in reducing inflammation in fibrosis in NASH?